Bone markers and cardiovascular risk in type 2 diabetes patients.

Zwakenberg, Sabine R; van der Schouw, Yvonne T; Schalkwijk, Casper G; Spijkerman, Annemieke M W; Beulens, Joline W J

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Authors

Zwakenberg, Sabine R
van der Schouw, Yvonne T
Schalkwijk, Casper G
Spijkerman, Annemieke M W
Beulens, Joline W J

Type

Article

Language

Metadata

Show full item record

Title

Bone markers and cardiovascular risk in type 2 diabetes patients.

Published in

Cardiovasc Diabetol 2018; 17(1):45

Publiekssamenvatting

Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes.